SCHEMBL28536100

SCHEMBL28536100

[N-]=[N+]=NC1C=CCN(C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21335553 0.72
SCHEMBL22032719 0.70 TFPI2 (0.32)
SCHEMBL1220092 0.70 TFPI2 (0.32)
SCHEMBL22032663 0.70 TFPI2 (0.32)
SCHEMBL25235405 0.69 GRM8 (0.40)
SCHEMBL26122790 0.69 DPP7 (0.41)
SCHEMBL26100296 0.69 GRM8 (0.40)
SCHEMBL28995477 0.67 TFPI2 (0.30)
SCHEMBL504856 0.67 TFPI2 (0.30)
SCHEMBL13918252 0.64 ABAT (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107849015-B Benzimidazole derivatives as PAD4 inhibitors 葛兰素知识产权发展有限公司 2021-03-19 CN disclosed